Literature DB >> 4490662

Comparison of the bioavailability of aminophylline in a conventional base and in a continous-release base.

C Boroda, R B Miller, S T Leslie, E G Nicol, I Thomson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4490662     DOI: 10.1002/j.1552-4604.1973.tb00183.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  11 in total

Review 1.  Clinical pharmacokinetics of theophylline.

Authors:  R I Ogilvie
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

2.  The efficacy of Neo-Biphyllin Retard in asthmatic patients--a theophylline slow-releasing coated tablet.

Authors:  H Albrecht; C Messerli; M Scherrer
Journal:  Pneumonologie       Date:  1976-06-25

3.  Self-poisoning with sustained-release aminophylline: secondary rise in serum theophylline concentration after charcoal haemoperfusion.

Authors:  J M Connell; J F McGeachie; J Knepil; A Thomson; B Junor
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-27

4.  In vitro testing of controlled release theophylline preparations: Theolair, Theograd and Theolin.

Authors:  J P Crombeen; C J De Blaey
Journal:  Pharm Weekbl Sci       Date:  1983-04-29

5.  Pharmacokinetics of a sustained-release theophylline formulation.

Authors:  P W Trembath; S W Boobois
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

6.  Haematemesis during oral aminophylline treatment.

Authors:  A Mackay; L E Ramsay; M L Eppel; J S Oliver
Journal:  Postgrad Med J       Date:  1979-06       Impact factor: 2.401

7.  Combination of aminophylline (Phyllocontin Continus tablets) and salbutamol in the management of chronic obstructive airways disease.

Authors:  C J Clark; G Boyd
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

8.  Oral sustained-release aminophylline in medical inpatients: factors related to toxicity and plasma theophylline concentrations.

Authors:  L E Ramsay; A Mackay; M L Eppel; J S Oliver
Journal:  Br J Clin Pharmacol       Date:  1980-08       Impact factor: 4.335

9.  A controlled release papaverine tablet (Papacontin): a study in normal volunteers.

Authors:  R B Miller; S T Leslie; F M Black; C Boroda
Journal:  Br J Clin Pharmacol       Date:  1978-01       Impact factor: 4.335

10.  Effect of oral salbutamol and slow-release aminophylline on exercise tolerance in chronic bronchitis.

Authors:  A G Leitch; A Morgan; D A Ellis; G Bell; C Haslett; G J McHardy
Journal:  Thorax       Date:  1981-10       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.